Depression in adults.
Geddes
John
J
University of Oxford, Oxford, UK.
Butler
Rob
R
Hatcher
Simon
S
Cipriani
Andrea
A
Price
Jonathan
J
Carney
Stuart
S
Von Korff
Michael
M
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003511:Cyclohexanols / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy / Q000628:therapy*; D004565:Electroconvulsive Therapy; D006801:Humans; D020902:Hypericum; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use; D008517:Phytotherapy; D028321:Plant Preparations / Q000627:therapeutic use; D011613:Psychotherapy; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D008996:Monoamine Oxidase Inhibitors; D009025:Morpholines; D028321:Plant Preparations; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride